Schedule 13G ownership disclosure

20/20 BIOLABS INC

Common Stock · CUSIP: 90138K101

Event date: 2026-02-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Streeterville Capital LLC

    Shares: 543,680.00 · Class: 9.9%

  • Streeterville Management, LLC

    Shares: 543,680.00 · Class: 9.9%

  • John M Fife

    Shares: 543,680.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001851416-26-000006
Form type
SCHEDULE 13G
Filer
20/20 Biolabs, Inc.
CIK
CIK 1139685
Filed
Feb 25, 2026
Reporting period
Feb 25, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub